GlassScriptPhysician profile
Hannah Lynch
NPI 1184233835
$5,960.50
in general payments reported to CMS, 2019-2025
12 companies · $4,601 in 2025
The $4,601 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.98 · 2023: $427 · 2024: $911 · 2025: $4,601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Food and Beverage: $2,139 · Travel and Lodging: $50.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Food and Beverage | $2,138.84 |
| Travel and Lodging | $50.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,330.95 | 2023-2025 | |
| Axsome Therapeutics, INC. | $356.60 | 2023-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $346.99 | 2023-2025 | Rexulti |
| Neuronetics, INC. | $316.83 | 2025 | Neurostar Tms Therapy System |
| Janssen Pharmaceuticals, INC | $263.44 | 2023-2025 | Spravato |
| Alkermes, INC. | $113.03 | 2024 | Vivitrol |
| Lundbeck LLC | $105.26 | 2024-2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $56.93 | 2024 | Qelbree |
| Indivior INC. | $20.98 | 2022 | |
| Vanda Pharmaceuticals INC. | $17.58 | 2025 | Fanapt |
| Tempus Ai, INC | $16.80 | 2024 | |
| Medline Industries LP | $15.11 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.